Insider Trading & Ownership of Cambridge Equities, LP

Location
El Segundo, CA
Summary
The estimated value of insider holdings of Cambridge Equities, LP is at least $572,646,382 dollars as of 20 Feb 2024. Cambridge Equities, LP is the 10%+ Owner of ImmunityBio, Inc. and owns shares of ImmunityBio, Inc. (IBRX) stock worth about $571.73M. Cambridge Equities, LP is the 10%+ Owner of Heliogen, Inc. and owns shares of Heliogen, Inc. stock worth about $915.6K.
Signature
//s/ Charles Kenworthy, Manager of MP 13 Ventures, on behalf of itself and as General Partner of Cambridge Equities
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Cambridge Equities, LP and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Cambridge Equities, LP has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $572,646,382.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ImmunityBio, Inc. ($571,730,825).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Cambridge Equities, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IBRX ImmunityBio, Inc. 10%+ Owner $571,730,825 31 Mar 2026
HLGN Heliogen, Inc. 10%+ Owner $915,557 15 Feb 2024

Insider Transactions Reported by Cambridge Equities, LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.